Veerhealth Care Reports Mixed Financial Results Amid Strong Sales Growth in March 2025

Veerhealth Care, a microcap company in the Pharmaceuticals & Biotechnology sector, has recently reported its financial results for the quarter ending March 2025. The results indicate a notable shift in the company's evaluation, with its score adjusting to 6 from 5 over the past three months.
The financial data reveals that net sales for the latest six months reached Rs 9.46 crore, reflecting a year-on-year growth of 51.60%. This positive sales trend suggests a robust performance in the near term. Additionally, the profit after tax (PAT) for the nine-month period stands at Rs 0.27 crore, surpassing the Rs 0.15 crore recorded in the previous twelve months, indicating that the company has already exceeded its prior sales figures.

However, not all aspects of Veerhealth Care's financials are favorable. The operating profit (PBDIT) has reached its lowest point in the last five quarters at Rs -0.17 crore, and the profit before tax (PBT) has also declined to Rs -0.56 crore, marking a negative trend in these areas.

Overall, the financial results present a mixed picture for Veerhealth Care, highlighting both positive sales growth and challenges in profitability metrics.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.